Sponsor intelligence · OTHER
Clinical trials sponsored by
Peking University Cancer Hospital & Institute.
Real, source-linked trial activity for Peking University Cancer Hospital & Institute: 4 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 20, 2026. Source-linked, daily-refreshed.
N/A 3PHASE1/PHASE2 1
Newest Peking University Cancer Hospital & Institute trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 4d ago | Risk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, | N/A | NOT_YET_RECRUITING | ↗ |
| 23d ago | SLNB Combined With WLNB for Axillary De-escalation in Breast Cancer Pa | N/A | NOT_YET_RECRUITING | ↗ |
| 47d ago | Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Canc | N/A | ACTIVE_NOT_RECRUITING | ↗ |
| 58d ago | 18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunother | Ph 1/Ph 2 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Peking University Cancer Hospital & Institute (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.